Last reviewed · How we verify
NCT03843866: STILS
Sutures Versus Glue in Laparoscopic Port Site Closure.
NA trial testing 4-0 Monocryl in Cosmetic Outcome in 200 participants. Status unknown.
1 July 2019
Quick facts
| Lead sponsor | St. James's Hospital, Ireland |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 200 |
| Start date | 11 February 2019 |
| Primary completion | 1 July 2019 |
| Estimated completion | 2 September 2019 |
| Sites | 1 location across Ireland |
Drugs / interventions tested
- 4-0 Monocryl
- Adhesive Glue
Conditions studied
- Cosmetic Outcome — all drugs for Cosmetic Outcome →
- Infection — all drugs for Infection →
- Cost — all drugs for Cost →
Sponsor
St. James's Hospital, Ireland
Who can join
18 and older, any sex, with Cosmetic Outcome or Infection. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cosmesis postoperatively is an important consideration for both patients and surgeons and consequently surgeons have become increasingly interested in replacing conventional sutures by means of adhesive bonds for the closure of skin wounds. Therefore the investigators are using two different close techniques for laparoscopic wounds. These are; 1. sutures with steri-strips and 2. adhesive bond.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Evaluating the use of absorbable sutures versus sTaples versus tIssue glue in laparoscopic port skin closure (STILS) trial: A prospective, multi-centre randomised clinical trial (RCT).
Ramjit SE, Davey MG, Keelan S, Herlihy E, et al · · 2025 · cited 1× · PMID 40102141 · DOI 10.1016/j.surge.2025.02.015
Verify or expand the search:
- PubMed search for NCT03843866
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other St. James's Hospital, Ireland trials
Trials by the same sponsor.
- NCT06550063 — HER2 Status in Esophagogastric Adenocarcinoma and Its Associations With Patient's Clinicopathological Outcomes · recruiting
- NCT05169645 — STOP CSUA: phySical acTivity, mOod and sleeP in Chronic Spontaneous Urticaria and Angioedema · unknown
- NCT04974931 — Application of PREVENA in Reducing Surgical Site Complications Following Reversal of Ileostomy or Colostomy · NA · unknown
- NCT03871023 — Prophylactic Negative Wound Therapy in Laparotomy Wounds. · NA · unknown
- NCT04152044 — Obesity and Liver Function in Oesophageal Cancer · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03843866 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by St. James's Hospital, Ireland
- Last refreshed: 20 February 2019
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03843866.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing